Greencamp

FEBRUARY 2, 2019

Even though cannabis and cannabinoid-derived pharmaceuticals are both frequently used by HIV/AIDS patients, several studies show that something interesting happens when cannabis is consumed. Examples include pneumonia, cancers, tuberculosis, chronic diarrhea, and inflammation-based conditions such as meningitis and encephalitis.

Marijuana

Greencamp

JANUARY 5, 2019

Schizophrenia is a mental condition which alters numerous important brain functions and subsequently the way a person feels, thinks and acts. It’s also very hard to predict who will develop this psychiatric disorder, but people whose first-degree relative suffers from schizophrenia are far more likely to develop the same condition.

Research and Development

Healer

DECEMBER 17, 2021

Drug interactions reported in the scientific literature most often occur at very high doses used in clinical trials of epilepsy and other conditions. Patients using warfarin need to have their blood INR level tested after adding THC-containing cannabis to their regimen. topiramate. rufinamide. zonisamide. eslicarbazepine.

CBD

Veriheal

MARCH 20, 2023

In 2006, the first research paper by Johns Hopkins was published on the positive long-term impact of using psilocybin in a therapeutic study. Both Colorado and Oregon allow patients to take psilocybin under the supervision of regulated and licensed “healing centers.” Colorado has a wider range of psilocybin use. Missouri Rep.

Clinical Trials

Miss Marijuana

OCTOBER 16, 2020

In 1998, Measure 8, also known as Alaska Medical Marijuana Initiative, was voted into act that would allow medical patients to use cannabis for treatment of debilitating conditions. A re-criminalization act was introduced in 2006, but then was decriminalized again in 2014, making marijuana-use by adults legal.

Marijuana

Alchimia

MARCH 16, 2016

Once the disease starts affecting the person, life expectancy greatly depends on patients (from 3 to 20 years), with an average of 8,5 years. Patient associations estimate that we’ll have around 1,5 million people suffering from Alzheimer in Spain by 2050. Cannabis patient. Source: Spanish Society of Neurology ).

Cannabinoids

Canna Care Docs

FEBRUARY 1, 2023

Since 2006, Rhode Island medical patients with qualifying conditions have enjoyed medical cannabis. Delivery and Wait Times Medical cannabis patients have the ability to order their cannabis ahead of time and pick it up curbside. This is not available for recreational users.

Recreational

SpeedWeed

FEBRUARY 28, 2021

TheraTrue is committed to using extensive research and cutting-edge technology to provide vertically integrated production facilities designed to safely deliver medical grade cannabis products to patients in Georgia and Virginia. For media inquiries, contacts or questions, please email [email protected]. . Background. TheraTrue, Inc.

Research and Development

Canna Care Docs

JULY 29, 2019

She said it “just barely covers the pain” of her condition. Compared with the 2006-2007 survey, the increases are 100% for 50- to 64-year-olds and 625% for 65 or older. She said about 24%, nearly one out of four, of their patients are ages 60 to 74, and another 10% are over 75. Around Christmastime last year, Ms.

Chronic Pain

Healer

DECEMBER 17, 2021

Drug interactions reported in the scientific literature most often occur at very high doses used in clinical trials of epilepsy and other conditions.[1]. Patients using warfarin need to have their blood INR level tested after adding THC-containing cannabis to their regimen. topiramate. rufinamide. zonisamide. eslicarbazepine.

CBD

Cannabis Law Report

NOVEMBER 24, 2021

Medicinal cannabis has been legalised for use for a range of specified medical conditions in Australia since 2016. However, the nature of the government regulations and the subsequent complexity of prescribing, as well as doctors’ safety uncertainties and the stigma of the plant, remain contributing barriers to patient access.

Research and Development

Corante

FEBRUARY 26, 2020

This concept was introduced by Ethan Russo who, in 2006, performed research on the genetic analysis of cannabis plants in a paper entitled, Phytochemical and genetic analyses of ancient cannabis from Central Asia. Along with greater availability comes greater potential to treat a wider variety of health conditions.

Strains

The Cannigma

APRIL 7, 2022

I was going to live at a place he was buying an Eagle Rock and this guy from Berkeley came in, Don Duncan, who had helped start Berkeley Patients Group and was going to open up LAPCG in Los Angeles. So I did, I open up a dispensary in Eagle Rock in 2006 with a couple of partners called Cornerstone Research Collective.

Terpenes

Cannabis Law Report

SEPTEMBER 23, 2019

Marijuana and related substance misuse are complex issues impacting family medicine, patient health, and public health. Barriers to facilitating both clinical and public health research regarding marijuana is detrimental to treating patients and the health of the public. Executive Summary. Relevant AAFP Policy. Call to Action.

Cannabinoids

Cannabis Law Report

SEPTEMBER 3, 2019

Subsequent to quarter end, Harborside exercised its merger option to acquire 100% ownership of Patients Mutual Collective Corporation (“PMACC”), which operates the retail Harborside dispensaries in Oakland and San Jose. and a concurrent private placement financing which raised approximately $15.0

Retail

Greencamp

JANUARY 22, 2019

Conditions that are most affected by chronic inflammation are: Migraines and headaches. For all these conditions it is crucial to suppress the immune system response, and this can be achieved by consuming precise and regulated doses of cannabinoids. This function is best visible in the case of cancer and HIV/AIDS patients.

Cannabinoids

CannaMD

OCTOBER 7, 2019

Besides going against all the classic “munchies/stoner” stereotypes, this finding is especially puzzling as cannabis is often used to increase weight gain in patients with medical conditions such as HIV/AIDS and cancer. So why are medical marijuana patients gaining weight when they need to, but losing weight when they don’t?

Marijuana

Canna Law Blog

NOVEMBER 1, 2020

In 2006, a measure that would have legalized medical cannabis failed to pass with a majority of 52 percent of South Dakota voters opposed. Initiated Measure 26, on the other hand, would legalize cannabis for medical use by patients with debilitating conditions and establish a medical cannabis program.

Legalization

Greencamp

AUGUST 16, 2018

Because of the very rapid progression of ALS in the majority of patients, understanding how cannabis could help in the alleviation of symptoms is incredibly important for ALS sufferers. Both upper and lower motor neurons suffer severe damage in ALS patients. As few as 10% of ALS patients live longer than 10 years after being diagnosed.

Strains

Cannabis Law Report

JANUARY 23, 2022

GVHD affects a significant portion of transplant patients, anywhere between 30% and 70% of patients depending on how closely the donor’s tissue matches with the patient. The team recruited 48 Patients with leukaemia or myelodysplastic syndrome. No grades III to IV toxicities were attributed to CBD. Implications.

Research and Development

Cannabis Law Report

JULY 12, 2019

Side effects were very prevalent in 79% of all patients taking a refined CBD product, some of which were severe like thrombocytopenia and transaminase elevations in the liver. Review: During an open-label trial of pure CBD with Lennox-Gastaut and Dravet patients, 79% of all patients reported side effects.

Extraction

MMJ Recs

APRIL 19, 2018

Between 2006 and 2013, the use of cannabis by senior citizens (over the age of 65) increased by an astounding 250 percent. Additionally, medical cannabis can be useful in treating pain – without the patient having to rely on harmful prescription painkillers. Around 80 percent of deaths related to anorexia are among elderly patients.

Chronic Pain

Cannabis Law Report

FEBRUARY 1, 2020

There are now over 1,000 registered patients receiving medical marijuana products by prescription, and this number is projected to surge to 400,000 by 2028. Nonetheless, medical cannabis isn’t accessible to everyone, even those with qualifying medical conditions and an authorised prescription. billion in 2018 alone. NEW ZEALAND.

Legalization

Cannabis Law Report

OCTOBER 29, 2019

Dr. Wakshlag and ElleVet are currently conducting additional clinical trials to demonstrate the efficacy of ElleVet hemp CBD/CBDA in other important conditions. The population we used in our investigation was representative of dogs presenting in a clinical setting for management of OA and represents the typical OA patient.

Safety

SpeedWeed

JUNE 9, 2021

At least 68 people died after contracting VAPI, or EVALI, the deadly lung condition caused by inhaling vaporized Vitamin E oil. More recently, a cancer researcher in Israel proposed a study of delta-8 THC to figure out how effective certain doses of delta-8 THC would be in alleviating nausea in cancer patients undergoing chemotherapy.

THC

SpeedWeed

FEBRUARY 19, 2021

Egyptian medical applications of cannabis show an astute knowledge of the efficacy of herbal remedies, and virtually all of their remedies containing it utilize it in a way in which cannabis has been known to be medically effective (Russo, 2006/2007). Both eyes of the patient are to be washed with it in the morning.”.

Research and Development

Cannabis Law Report

MARCH 25, 2019

The DEA has made previous requests–in 2001 and 2006–to the FDA for an evaluation of marijuana. 9, 2006 , 120 Stat. 201, July 27, 2006 , 120 Stat. 10, 2006 , 119 Stat. 9, 2006 , 120 Stat. 9, 2006 , 120 Stat. 3005(a), title IV, § ? 4002(d)(2)(A), Nov. 2, 2002 , 116 Stat. 1805 , 1809; Pub.

Banking